An inhalation medicament comprising orazipone and a beta2-adrenoreceptor agonist and/or a corticosteroid as a combined preparation. Optionally the medicament also comprises one or more pharmaceutically acceptable additive, diluents or carriers. The beta-2adrenoreceptor agonist and the corticosteroid may comprise, respectively, formoterol and budesonide.
一种吸入药剂,由奥拉西朋和β2-
肾上腺素受体激动剂和/或皮质类
固醇组合而成。药剂还可选择包含一种或多种药学上可接受的添加剂、稀释剂或载体。2-
肾上腺素受体激动剂和皮质类
固醇可分别包括
福莫特罗和
布地奈德。